Allosteric and ATP-Pocket BCR::ABL1 Inhibition In Vitro, and Characterising Ex Vivo Thrombo-Inflammatory Biomarkers and Thrombin Generation in Asciminib-Treated CML Patients. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.